Zai Lab Shares Updated Phase 1 Data for DLL3-Targeted ADC in SCLC, Launches Global Phase 3
Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has released…